AstraZeneca Pharma India Technical Analysis
- Market cap
- ₹14,808 crore
- P/E
- 87.3
- P/B
- 16.97
- ROE
- 22.8%
- Dividend yield
- 0.61%
As of 7 October 2026, AstraZeneca Pharma India (ASTRAZEN) closed at . The 14-day RSI is 58.50, between the oversold (30) and overbought (70) levels.
AstraZeneca Pharma India moving averages
Last close on 7 Oct 2026. "Price vs" shows whether the close is above or below each average.
| Period | SMA | Price vs SMA | EMA | Price vs EMA |
|---|---|---|---|---|
| 5-day | 5,863.77 | — | 5,863.77 | — |
| 10-day | 5,804.54 | — | 5,804.54 | — |
| 20-day | 5,745.31 | — | 5,745.31 | — |
| 50-day | 5,626.85 | — | 5,626.85 | — |
| 100-day | 5,449.16 | — | 5,449.16 | — |
| 200-day | 5,212.24 | — | 5,212.24 | — |
AstraZeneca Pharma India momentum indicators
| RSI (14) | 58.50 |
|---|---|
| MACD (12, 26) | 12.40 |
| MACD signal (9) | 10.20 |
| MACD histogram | — |
| ADX (14) | 24.20 |
| Stochastic %K / %D (14, 3) | 65.00 / 60.00 |
AstraZeneca Pharma India trend
Close compared with its 20-day (short), 50-day (medium) and 200-day (long) simple moving averages.
- Short term (20-day)
- —
- Medium term (50-day)
- —
- Long term (200-day)
- —
Source: Calculated by ATS from NSE end-of-day closing prices (adjusted for splits and bonus issues), last 365 days. Data as of 7 October 2026. How this data is compiled.
AstraZeneca Pharma India technical analysis — frequently asked questions
What is the 200-day moving average of AstraZeneca Pharma India?
AstraZeneca Pharma India's 200-day simple moving average was ₹5,212.24 on 7 October 2026, and its 200-day exponential moving average ₹5,212.24. The last close of is below the 200-day SMA.
Is AstraZeneca Pharma India above its 50-day moving average?
No — on 7 October 2026 AstraZeneca Pharma India closed at , against a 50-day simple moving average of ₹5,626.85.
What is the RSI of AstraZeneca Pharma India?
The 14-day Relative Strength Index for AstraZeneca Pharma India was 58.50 on 7 October 2026, between the oversold (30) and overbought (70) levels. RSI measures the speed of recent price changes on a 0–100 scale.
What is the MACD of AstraZeneca Pharma India?
On 7 October 2026 the MACD (12, 26, 9) line for AstraZeneca Pharma India was 12.40 and the signal line 10.20, so the MACD was above its signal line.
How are these AstraZeneca Pharma India technical indicators calculated?
ATS calculates them from the NSE's daily closing prices for the last 365 days, adjusted for splits and bonus issues: simple and exponential moving averages over 5 to 200 sessions, a 14-day RSI with Wilder smoothing, MACD (12, 26, 9) and a 14-day ADX. They describe past prices and are not a forecast or a recommendation.
Same Data For Peers
Trade AstraZeneca Pharma India With ATS
Track ASTRAZEN live and place orders from the Pocket app or the Pocket Web terminal with an ATS trading and demat account.
Figures are for information only and are not investment advice or a recommendation to buy, sell or hold any security. Investments in securities are subject to market risks; read all related documents carefully before investing.